NIS基因转染肿瘤细胞介导131I治疗
Transfection of the Na+/I- symporter gene into tumors for radioiodide therapy
-
摘要: 钠/碘同向转运体(NIS)是一种跨膜糖蛋白,具有主动运输碘的能力。NIS的异常与许多甲状腺疾病有关。将NIS基因转染到肿瘤细胞使其表达NIS并摄取131I已获成功,但131I在细胞或病灶内停留的时间很短,达不到治疗剂量,故延长131I的有效半衰期和提高NIS转染率是今后研究的方向。Abstract: Na+/I- symporter is a membrane glycoprotein that catalyzes the active accumulation of I-. The abnormality of NIS gene will lead to thyroid disease. We had succeeded in transfecting the Na+/I- symporter into tumors for radioiodide concentration. However, the effective half life is too short to acquire therapeutic dose. So we should research into prolonging the effective half-life and increased effective transfection.